IGC Pharma (IGC) Cash & Equivalents (2010 - 2026)
IGC Pharma (IGC) posted Cash & Equivalents of $207,000 for Q4 2026, down 48.9% from $405,000 a year earlier and down 77.0% from the prior quarter.
Powered by 
Analysis
IGC Pharma (IGC) Cash & Equivalents (2010 - 2026) Analysis & Trends
Since Q1 2011, IGC Pharma has reported Cash & Equivalents for 64 quarters.
- Annual Cash & Equivalents has declined for five consecutive years, with a five-year compound annual growth rate of -57.3% (FY2021 to FY2026).
- In prior years, IGC Pharma's Cash & Equivalents was $405,000 in FY2025 (-66.3%), $1.2 million in FY2024 (-62.5%), $3.2 million in FY2023 (-69.4%) and $10.46 million in FY2022 (-28.1%).
- The Q4 2026 figure stands as the lowest quarterly Cash & Equivalents in data going back to Q1 2011.
- On a year-over-year basis, Cash & Equivalents increased in two of the last eight quarters, with an average decline of 29.5%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q1 2022, with growth of 392.7%; the weakest was Q1 2024, with a decline of 78.6%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $900,000 (Q3 2026), $1.11 million (Q2 2026) and $454,000 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | IGC Pharma | 26.67 Mn | 23.92 Mn | 55,000.00 | 207,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 207,000.00 |
| Dec 31, 2025 | 900,000.00 |
| Sep 30, 2025 | 1.11 Mn |
| Jun 30, 2025 | 454,000.00 |
| Mar 31, 2025 | 405,000.00 |
| Dec 31, 2024 | 470,000.00 |
| Sep 30, 2024 | 1.55 Mn |
| Jun 30, 2024 | 1.82 Mn |
| Mar 31, 2024 | 1.20 Mn |
| Dec 31, 2023 | 1.38 Mn |
| Sep 30, 2023 | 3.03 Mn |
| Jun 30, 2023 | 1.72 Mn |
| Mar 31, 2023 | 3.20 Mn |
| Dec 31, 2022 | 4.95 Mn |
| Sep 30, 2022 | 6.62 Mn |
| Jun 30, 2022 | 8.05 Mn |
| Mar 31, 2022 | 10.46 Mn |
| Dec 31, 2021 | 11.94 Mn |
| Sep 30, 2021 | 14.40 Mn |
| Jun 30, 2021 | 13.32 Mn |
API Access
IGC Pharma Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IGC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "IGC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IGC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();